Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Immunologic Factors”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT05284097
What this trial is testing

Ad26.ZEBOV, MVA-BN-Filo Vaccination in Children and Adults Previously Vaccinated With Control in the EBOVAC-Salone Study

Who this might be right for
Virus DiseasesHemorrhagic Fever, EbolaInfections+8 more
London School of Hygiene and Tropical Medicine 133
Not applicableUnknownNCT04151186
What this trial is testing

A Clinical Study on the Safety and Efficacy of CAR-T Therapy for the TM4SF1- and EpCAM-positive Solid Tumors

Who this might be right for
Advanced Solid TumorNeoplasms
suhaichuan 72
Not applicableStudy completedNCT00073424
What this trial is testing

Factors Affecting Adherence to Anti-HIV Drug Regimens in Children and Adolescents

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 200
Not applicableStudy completedNCT02264509
What this trial is testing

Peripheral Arterial Insufficiency Associated With HIV/AIDS

Who this might be right for
Arterial InsufficiencyAcquired Immunodeficiency SyndromeHIV
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran 206
Not applicableStudy completedNCT03690648
What this trial is testing

Genetic Factors and Immunological Determinism of Persistent Consequences of Chikungunya

Who this might be right for
Chikungunya Fever
Centre Hospitalier Universitaire de la Réunion 600
Testing effectiveness (Phase 2)Looking for participantsNCT05826535
What this trial is testing

Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma

Who this might be right for
Relapsed Non-Hodgkin LymphomaRefractory Non-Hodgkin LymphomaNon-Hodgkin Lymphoma+1 more
Lyell Immunopharma, Inc. 270
Testing effectiveness (Phase 2)Ended earlyNCT01435356
What this trial is testing

Safety and Efficacy Study of MAGE-A3 + AS-15 in Patients With Muscle-invasive Bladder Cancer After Cystectomy

Who this might be right for
Urinary Bladder Neoplasms
European Association of Urology Research Foundation 83
Not applicableStudy completedNCT00007319
What this trial is testing

Carotid Artery Thickness in HIV Infected and Uninfected Adults

Who this might be right for
HIV InfectionsHIV SeronegativityAtherosclerosis
National Institute of Allergy and Infectious Diseases (NIAID) 132
Early research (Phase 1)Study completedNCT01384253
What this trial is testing

Safety Study of ²¹²Pb-TCMC-Trastuzumab Radio Immunotherapy

Who this might be right for
Breast NeoplasmsPeritoneal NeoplasmsOvarian Neoplasms+2 more
Orano Med LLC 18
Testing effectiveness (Phase 2)UnknownNCT04130594
What this trial is testing

Study of Safety and Immunogenicity of BVRS-GamVac

Who this might be right for
MERS (Middle East Respiratory Syndrome)MERS
Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation 162
Testing effectiveness (Phase 2)Study completedNCT03942406
What this trial is testing

Study of BPZE1 Intranasal Pertussis Vaccine (Administered Via VaxINator(TM)), Prime + Boost, in Healthy Adults

Who this might be right for
PertussisWhooping Cough
ILiAD Biotechnologies 300
Testing effectiveness (Phase 2)UnknownNCT05375240
What this trial is testing

Propranolol on Post Stroke Immune Status and Infection

Who this might be right for
StrokeCerebrovascular DisordersIschemic Stroke+9 more
Tianjin Medical University General Hospital 45
Not applicableStudy completedNCT00001330
What this trial is testing

Study of Silicone-Associated Connective Tissue Diseases

Who this might be right for
Autoimmune DiseasesConnective Tissue DiseasesScleroderma, Circumscribed+1 more
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) 60
Testing effectiveness (Phase 2)Active Not RecruitingNCT02912949
What this trial is testing

Zenocutuzumab (MCLA-128) in Patients With Solid Tumors Harboring an NRG1 Fusion (eNRGy)

Who this might be right for
Solid Tumours Harboring NRG1 FusionNSCLC Harboring NRG1 FusionPancreatic Cancer Harboring NRG1 Fusion+1 more
Partner Therapeutics, Inc. 250
Testing effectiveness (Phase 2)Study completedNCT03369223
What this trial is testing

BMS-986249 Alone and in Combination With Nivolumab in Advanced Solid Tumors

Who this might be right for
Advanced Cancer
Bristol-Myers Squibb 356
Not applicableStudy completedNCT00023582
What this trial is testing

HIV and Genital Herpes Among High-Risk Men Who Have Sex With Men (MSM) in Lima, Peru

Who this might be right for
HIV InfectionsHerpes GenitalisHIV Seronegativity+1 more
National Institute of Allergy and Infectious Diseases (NIAID) 250
Testing effectiveness (Phase 2)UnknownNCT04128059
What this trial is testing

Study of Safety and Immunogenicity of BVRS-GamVac-Combi

Who this might be right for
MERS (Middle East Respiratory Syndrome)MERS
Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation 268
Not applicableLooking for participantsNCT06137196
What this trial is testing

Risk Identification Factors for Pulmonary Function Impairment in AIDS Patients Recovered From Severe Pneumonia

Who this might be right for
AIDSPneumonia
Guangzhou 8th People's Hospital 100
Not applicableLooking for participantsNCT04335773
What this trial is testing

COVID-19 in Hospitalised Norwegian Children - Risk Factors, Outcomes and Immunology

Who this might be right for
Pediatric Respiratory DiseasesCOVIDFatigue Post Viral
University Hospital, Akershus 350
Not applicableStudy completedNCT02092558
What this trial is testing

Evaluation of Immunological Disorders of T Lymphocytes and Endocrinological Disorders as Pathogen Factors in Patients With Metaplasia of Urinary Bladder

Who this might be right for
The Follow-up Duration Was 1-8 Years.The Main Reasons Behind Visiting the Hospital Were Recurrent Urinary Tract Infection,Urinary Urgencies, Pollakiuria, Difficulty in Initiating Micturition, Pain in Hypogastrium,+2 more
Children's Hospital, Dziekanów Leśny, Poland
Next Page
2